13F Holdings
中文EN

AIRS Airsculpt Technologies, Inc.

Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 1870940 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-6.3%
TTM net income YoY47.7%
TTM EPS YoY60.0%
Revenue 3-yr CAGR-7.9%
Net income 3-yr CAGR—

Margins

Gross margin60.2%
Operating margin-4.7%
Net margin-6.4%
FCF margin-1.7%
EBITDA margin3.4%

Returns

ROE-10.1%
ROA-5.0%
ROIC (approx.)-4.2%
Asset turnover0.79x

Leverage & solvency

Liabilities / assets43.6%
Debt / equity0.35x
Current ratio0.85x
Interest coverage-1.40x

Cash quality & payout

Operating cash flow / net income0.21x
Accruals ratio-4.0%
Payout ratio—
Capex / revenue0.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$151.82M$180.35M$195.92M$168.79M$133.31M
Cost of revenue$61.69M$71.15M$73.77M$62.78M$44.54M
Gross profit$90.13M$109.20M$122.14M$106.01M$88.78M
SG&A expense$82.18M$98.88M$102.38M$101.42M$65.73M
Operating income-$11.56M-$1.58M$9.72M-$4.54M$15.77M
Interest expense$6.08M$6.25M$6.49M$6.75M$4.89M
Pretax income-$17.64M-$7.83M$3.24M-$11.30M$10.88M
Income tax-$5.97M$188,000$7.48M$3.38M$329,000
Net income-$11.67M-$8.02M-$4.24M-$14.68M$10.55M
EBITDA$1.22M$10.30M$19.98M$3.52M$22.36M
EPS (basic)-0.19-0.14-0.08-0.26-0.01
EPS (diluted)-0.19-0.14-0.08-0.26-0.01
Dividends declared per share———0.41—
Weighted avg. shares (diluted)60.45M57.69M56.78M55.68M55.64M
Balance sheet
Cash & equivalents$8.45M$8.23M$10.26M$9.62M$25.35M
Current assets$15.46M$17.12M$15.96M$16.68M$29.44M
PP&E, net$27.81M$37.47M$28.91M$24.21M$13.63M
Goodwill$81.73M$81.73M$81.73M$81.73M$81.73M
Intangibles$36.84M$41.59M$46.35M$51.10M$55.85M
Total assets$187.30M$212.78M$204.02M$200.76M$200.55M
Current liabilities$27.90M$28.95M$20.32M$22.32M$16.41M
Short-term debt$5.46M$4.25M$2.12M$2.12M$850,000
Long-term debt$50.59M$65.46M$69.50M$81.42M$81.75M
Total debt$56.05M$69.71M$71.63M$83.55M$82.61M
Total liabilities$99.59M$134.59M$120.03M$129.99M$117.03M
Shareholders' equity$87.71M$78.19M$82.66M$70.77M$83.53M
Net debt$47.60M$61.47M$61.37M$73.93M$57.26M
Shares outstanding64.54M58.37M57.36M56.18M55.64M
Cash flow statement
Operating cash flow$3.10M$11.35M$23.96M$24.45M$26.63M
Capital expenditure$2.40M$14.01M$9.92M$12.92M$7.12M
Free cash flow$692,000-$2.66M$14.04M$11.53M$19.52M
Investing cash flow-$2.40M-$14.01M-$9.92M-$12.92M-$7.12M
Financing cash flow-$478,000$630,000-$13.39M-$27.26M-$4.55M
Depreciation & amortization$12.78M$11.89M$10.25M$8.06M$6.60M
Stock-based compensation$2.33M$3.76M$18.22M$29.46M$7.18M
Dividends paid$0$252,000$385,000$23.16M$0

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.